Ranked roughly by how strongly each one predicts a bad outcome.
- Rules not published before purchase. If you must buy to read the terms, do not buy.
- A consistency rule with no stated threshold. That is a discretionary veto over your payout.
- Trailing drawdown described only as "maximum drawdown." Vagueness here is deliberate.
- Payout terms that appear only after you pass. New conditions at the withdrawal step are the classic failure mode.
- No named legal entity or registered address. A logo is not a company.
- Support that answers rule questions with marketing copy. Test this before you pay — it is free.
- Payout proof that is all from launch week. Recent and repeated matters; a burst does not.
- Aggressive discounting that never ends. A permanent 50% sale means the list price is fiction.
- Lifestyle marketing rather than trading content. Firms selling rented cars are not selling a trading business.
- Reviews that are all five stars or all one star. Both patterns indicate manipulation somewhere.
- No clear statement about whether accounts are simulated. This should be unambiguous and prominent.
- Rule changes applied retroactively to existing accounts. Check the terms for whether they can.
There is a structured way to turn this into a decision in how to compare prop firms.
Frequently asked questions
What are the warning signs of a bad prop firm?
Rules not published before purchase, a consistency rule with no stated threshold, vague drawdown wording, payout terms that only appear after you pass, and no named legal entity. Any one of these justifies walking away.
How do I check a prop firm before paying?
Read the full rule sheet, confirm whether the maximum loss is static or trailing, look for recent and repeated payout evidence across multiple traders, and email support three specific rule questions to test how they answer.
FundedAxe evaluations and funded accounts are simulated. Traders do not trade real client capital; rewards are paid on simulated performance under the terms of the FundedAxe trader agreement.